These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8268064)

  • 1. Phospholipid metabolites, prognosis and proliferation in human breast carcinoma.
    Smith TA; Bush C; Jameson C; Titley JC; Leach MO; Wilman DE; McCready VR
    NMR Biomed; 1993; 6(5):318-23. PubMed ID: 8268064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma.
    al-Alwan NA
    East Mediterr Health J; 2000; 6(5-6):1062-72. PubMed ID: 12197329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visibility of phospholipids in 31P NMR spectra of human breast tumours in vivo.
    Lowry M; Porter DA; Twelves CJ; Heasley PE; Smith MA; Richards MA
    NMR Biomed; 1992; 5(1):37-42. PubMed ID: 1550708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study.
    Taylor-Robinson SD; Thomas EL; Sargentoni J; Marcus CD; Davidson BR; Bell JD
    Biochim Biophys Acta; 1995 Oct; 1272(2):113-8. PubMed ID: 7548234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
    Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
    Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer and prognostic factors. Tumour size, degree of differentiation, proliferation kinetics and expression of steroid hormone receptors.
    Mink D; von Tongelen B; Villena-Heinsen C; Heiss C; Schmidt W
    Eur J Gynaecol Oncol; 1994; 15(6):424-36. PubMed ID: 7875157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in breast cancer: relationship with other pathological parameters.
    Lipponen P
    Endocr Relat Cancer; 1999 Mar; 6(1):13-6. PubMed ID: 10732780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate.
    Smith TA; Eccles S; Ormerod MG; Tombs AJ; Titley JC; Leach MO
    Br J Cancer; 1991 Nov; 64(5):821-6. PubMed ID: 1931601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumours.
    Smith TA; Baluch S; Titley JC; Ormerod MG; Eccles S; Tombs AJ; Leach MO; Griffiths JR; McCready VR
    NMR Biomed; 1993; 6(3):209-14. PubMed ID: 8347455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma.
    Spiethoff A; Schenck A; Bohrer M
    J Cancer Res Clin Oncol; 2000 Dec; 126(12):707-10. PubMed ID: 11153143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the proliferation rate on the course of node negative breast carcinoma].
    Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Male breast cancer. Histochemical and flow cytometry analysis of 6 cases].
    Galasso MG; Galia A; Gazzano G; Cosentino A; Castorina S
    Pathologica; 1995 Oct; 87(5):503-5. PubMed ID: 8868175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy and pS2 protein expression in breast cancer.
    Ioakim-Liossi A; Karakitsos P; Aroni K; Markopoulos C; Delivelioti K; Gogas J; Kyrkou K
    Cytopathology; 1997 Jun; 8(3):171-6. PubMed ID: 9202892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Ki67 growth fraction and oestrogen receptors in screen-detected breast cancer using cytological preparations.
    Coddington R; Cuthbert A; Campbell ID; Herbert A; Theaker JM; Royle GT; Taylor I
    Cytopathology; 1993; 4(5):257-66. PubMed ID: 8274663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.
    Mimmi MC; Finato N; Pizzolato G; Beltrami CA; Fogolari F; Corazza A; Esposito G
    Anal Cell Pathol (Amst); 2013; 36(3-4):71-83. PubMed ID: 24036926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
    Cook DL; Weaver DL
    Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
    Pinto AE; Pereira T; Silva GL; André S
    Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
    Clarke RB; Laidlaw IJ; Jones LJ; Howell A; Anderson E
    Br J Cancer; 1993 Mar; 67(3):606-11. PubMed ID: 8439511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.